prikaz prve stranice dokumenta Why we should not recommend or offer fluvoxamine to COVID-19 patients?
  Preuzmi
PDF 284.41 KB
Stručni rad - Pismo uredniku
Why we should not recommend or offer fluvoxamine to COVID-19 patients?
European Journal of Clinical Pharmacology, 79 (2023), 2; 321-322. https://doi.org/10.1007/s00228-022-03447-3
Trkulja, Vladimir

Citirajte ovaj rad

Trkulja, V. (2023). Why we should not recommend or offer fluvoxamine to COVID-19 patients?. European Journal of Clinical Pharmacology, 79. (2), 321-322. doi: 10.1007/s00228-022-03447-3

Trkulja, Vladimir. "Why we should not recommend or offer fluvoxamine to COVID-19 patients?." European Journal of Clinical Pharmacology, vol. 79, br. 2, 2023, str. 321-322. https://doi.org/10.1007/s00228-022-03447-3

Trkulja, Vladimir. "Why we should not recommend or offer fluvoxamine to COVID-19 patients?." European Journal of Clinical Pharmacology 79, br. 2 (2023): 321-322. https://doi.org/10.1007/s00228-022-03447-3

Trkulja, V. (2023) 'Why we should not recommend or offer fluvoxamine to COVID-19 patients?', European Journal of Clinical Pharmacology, 79(2), str. 321-322. doi: 10.1007/s00228-022-03447-3

Trkulja V. Why we should not recommend or offer fluvoxamine to COVID-19 patients?. European Journal of Clinical Pharmacology [Internet]. 02.2023. [pristupljeno 07.11.2024.];79(2):321-322. doi: 10.1007/s00228-022-03447-3

V. Trkulja, "Why we should not recommend or offer fluvoxamine to COVID-19 patients?", European Journal of Clinical Pharmacology, vol. 79, br. 2, str. 321-322, Veljača 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:779915. [Citirano: 07.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:779915
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Why we should not recommend or offer fluvoxamine to COVID-19 patients?
AutorVladimir Trkulja
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA TEMELJNU I KLINIČKU FARMAKOLOGIJU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Temeljne medicinske znanosti
Farmakologija
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeStručni rad - Pismo uredniku
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaEuropean Journal of Clinical Pharmacology
Brojčani podacivol. 79, br. 2, str. 321-322
p-ISSN0031-6970
e-ISSN1432-1041
DOIhttps://doi.org/10.1007/s00228-022-03447-3
URN:NBNurn:nbn:hr:105:779915
Datum objave publikacije2023-02
URL dokumentahttps://link.springer.com/10.1007/s00228-022-03447-3
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2023-05-15 11:00:51